ArticleProceedings of the National Academy of Sciences of the United States of America2017

Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer.

Jacqueline M Mason et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.